The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Native Copper Found in Nevada as 10,000-Foot Drill Program Advances
Source: Streetwise Reports (11/03/2026)

Copper One Resources Corp. (CEXY:CSE; CEXYF:OTCID; IW8:FSE) reported visible native copper and copper oxides in drill core from MHB-39, the first hole of its Phase 2 program at Majuba Hill in Nevada. The hole reached 1,460 feet, and the program is planned for up to 10,000 feet.

Pharma Co. Raises 2026 Guidance Amid Pancreatic Rival Pressure
Source: Streetwise Reports (11/03/2026)

Novocure Ltd. (NVCR:NASDAQ) reported record Q3 2026 revenue of US$193M, raised full-year guidance, and secured Japan approval for Optune Pax despite competition from KRAS inhibitors in pancreatic cancer.

Exploration Co. Confirms Copper Mineralization at La Grande Zone 32 in Québec
Source: Streetwise Reports (11/03/2026)

Lux Metals Corp (LXM:TSXV; BBBMF:OTCMKTS) reports copper assays confirming gold-copper mineralization at the Zone 32 La Grande project in Québec, with 0.71% Cu over 19.5 m, including high-grade subintervals.

Mining Co. Intersects Gold Below Nyam Reserve Pit in Ghana
Source: Streetwise Reports (11/02/2026)

Newcore Gold Ltd. (NCAU:TSXV; NCAUF:OTCQX) reports high-grade diamond drill results below the pits constraining Mineral Reserves at its Nyam deposit within the Enchi gold project in Ghana, including 2.16 g/t gold over 37 m.